Reports

227 Results (Page 1 of 10)

Egypt Markets Research Reports

Pharmaceuticals

Egypt Dermatological Therapeutics Market Analysis

Egypt Dermatological Therapeutics Market is at around $0.12 Bn in 2023 and is projected to reach $0.23 Bn in 2030, exhibiting a CAGR of 10.10% during the forecast period. The factors driving the expansion of the market are rising awareness, the prevalence of skin disorders, and advancements in treatment technologies. The market is dominated by key players like Egyptian International Pharmaceutical Co. (EPICO), Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Digital Health

Egypt Digital Therapeutics Market Analysis

Egypt Digital Therapeutics Market is at around $17 Mn in 2023 and is projected to reach $99.43 Mn in 2030, exhibiting a CAGR of 28.7 % during the forecast period. The development of healthcare infrastructure, provider acceptance, and partnerships and collaborations are driving market expansion. The market is dominated by key players like Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Alopecia (Hair Loss) Therapeutics Market Analysis

The Egypt Alopecia (Hair Loss) Therapeutics Market was valued at US $23 Mn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $46 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), improved socioeconomic conditions, and others. The industry is primarily dominated by players such as Sun Pharmaceuticals, Johnson & Johnson, Cirrus, Cipla, Lexington, and Merck, among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Allergy Therapeutics Market Analysis

Egypt Allergy Therapeutics Market was valued at $65 Mn in 2022 and is estimated to reach $119 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The need for allergy treatment medications is rising due to the frequency of allergic illnesses and related health issues. The top pharmaceutical companies that are currently operating in the market are Novartis, Sanofi, Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck & Co., Bayer, AstraZeneca, Roche and Teva Pharmaceutical Industries.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Alcohol Addiction Therapeutics Market Analysis

The Egypt Alcohol Addiction Therapeutics Market is valued at around $2 Mn in 2022 and is projected to reach $4 Mn by 2030, exhibiting a CAGR of 7.8% during the forecast period. The market growth in the country is fueled by the changing societal attitudes, increased middle-class discretionary incomes and the increased government’s efforts to improve healthcare facilities. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Egypt are Alkermes, Teva Pharmaceuticals, Addex Therapeutics, Opiant Pharmaceuticals, GlaxoSmithKline (GSK), Merck & Co., Pharos Holding, Egypharm, Amoun Pharmaceuticals, Egyptian International Pharmaceutical Marketing Co. (EIPMCO) etc among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Cardiovascular Drugs Market Analysis

Egypt Cardiovascular Drug Market is at around $0.4 Bn in 2022 and is projected to reach $0.6 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The market is expanding as a result of government initiatives, increased access to health insurance, and a rise in cardiovascular load. The market is dominated by key players like Copad Pharma, Menarini Pharmaceutical, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., F. Hoffman-La Roche, Pfizer Inc., Astra Zeneca, Sanofi, Novartis, and GSK.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis

The Egypt Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $9 Mn in 2022, and is predicted to grow at (CAGR) of 9.3% from 2023 to 2030, to US $19 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic Leukemia cases, expanding healthcare infrastructure by continuous investment, increased government funding initiatives and other factors. The industry is primarily dominated by players such as Pharco, EIPICO, Amoun, Novartis, among other players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis

The Egypt Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US$3 Mn in 2022, and is predicted to grow at a CAGR of 7.3% from 2023 to 2030, to US$5 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of autosomal dominant polycystic kidney disease, healthcare infrastructure growth, and other factors. The industry is primarily dominated by players such as Otsuka Pharmaceuticals, AceLink, Palladio, Reata, Xortx, Regulus, Exelixis, Sanofi, and other players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Age-Related Macular Degeneration Therapeutics Market Analysis

The Egypt Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $30 Mn in 2022 and is predicted to grow at a CAGR of 10.40% from 2023 to 2030, to US $67 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, a strong product pipeline, and other factors. The industry is primarily dominated by players such as Novartis, Bayer, Roche, Regeneron Pharmaceuticals, and Genetech, among others

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Addiction Therapeutics Market Analysis

Egypt addiction therapeutics market was valued at $28 Mn in 2022 and is estimated to reach $54 Mn in 2030, exhibiting a CAGR of 8.4% during the forecast period. The industry for addiction treatment is expanding as a result of public awareness raised by anti-drug campaigns and supportive government initiatives. Dominant key players operating in the market include Indivior, Alkermes, Reckitt Benckiser, Otsuka Pharmaceutical Co., Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical and Novartis

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Actinic Keratosis Therapeutic Market Analysis

Egypt actinic keratosis therapeutics market was valued at $19 Mn in 2023 and is expected to reach $31 Mn by 2030, growing at a CAGR of 6.4%. Factors like high UV radiation exposure in the subtropical climate, an aging population more prone to AK, raising public awareness through media and healthcare initiatives, and easier access to dermatological services are driving the growth of the Egypt Actinic Keratosis Therapeutic Market. Major pharmaceutical companies include Biofrontera, LEO Pharma, 3M, Bausch Health, Novartis, GlaxoSmithKline, Almirall, etc

PUBLISHED: Jan, 2024 | FORMAT: PPT | LAST UPDATED: Jan, 2024 | PRICE: $3999

Digital Health

Egypt eHealth Market Analysis

This report presents a strategic analysis of the Egypt eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt eHealth Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

Egypt Robotic Surgery Services Market Analysis

This report presents a strategic analysis of the Egypt Robotic Surgery Services Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Robotic Surgery Services Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Egypt Radiotherapy Market Analysis

By 2030, it is anticipated that the Egypt Radiotherapy Market will reach a value of $35 Mn from $19 Mn in 2022, growing at a CAGR of 7.5% during 2022-30. The Radiotherapy Therapeutics Market in Egypt is dominated by a few domestic players such as Accuray, Elekta, and Siemens Healthineers. The radiotherapy market in Egypt is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Egypt Radiotherapy is increasing on account of the rise in cancer cases in the country.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Egypt Liver Disease Drugs Market Analysis

This report presents a strategic analysis of the Egypt Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Liver Disease Drugs Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

Egypt Healthcare Claims Management Market Analysis

Egypt's healthcare claims management market is projected to grow from $74.76 Mn in 2022 to $442.76 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022-30. The main factors driving the growth would be rising health insurance coverage, increasing patient awareness and expectations, government initiatives, and growing demand for digital healthcare technology. The market is segmented by component, type, delivery mode, and by end-user. Some of the major players include MedMisr, Marsh, Cigna, Allianz and Accenture.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Egypt Growth Hormone Deficiency Clinical Trials Market Analysis

This report presents a strategic analysis of the Egypt Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Egypt ENT Devices Market Analysis

Egypt's ENT Devices Market is projected to grow from $60 Mn in 2022 to $110 Mn by 2030, registering a CAGR of 7.3% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Egypt ENT devices market include Alfa Medical, Al Amal Medical Supplies, and Misr Medicare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Digital Health

Egypt Digital Health Market Analysis

Egypt's Digital Health market is projected to grow from $0.59Bn in 2022 to $2.56Bn by 2030, registering a CAGR of 20.1% during the forecast period of 2022-30. The market will be driven by the rise in consumer awareness of digital health technologies and the government's persuasion toward nationwide digitization. The market is segmented by solution, by deployment & by end-use. Some of the major players include GE Healthcare, Siemens Healthineers & Vezeeta.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Egypt Dialysis Market Analysis

This report presents a strategic analysis of the Egypt Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Dialysis Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Egypt Diabetes Therapeutics Market Analysis

Egypt's diabetes therapeutics market is expected to witness growth from $403 Mn in 2022 to $942 Mn in 2030 with a CAGR of 11.2% for the forecasted year 2022-30. The higher prevalence rates of diabetes and the increased funding for the healthcare infrastructure in Egypt are responsible for the growth of the market. The Egypt diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Sovalue, Vortex Pharma, and AstraZeneca are the major players in the Egypt diabetes therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Egypt Diabetes Devices Market Analysis

Egypt's Diabetes Devices Market is expected to witness growth from $64 Mn in 2022 to $124 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. As healthcare expenditures in Egypt increase, a greater focus is being placed on preventive care and the management of chronic diseases. The demand for healthcare goods in general, including diabetes management devices, ought to increase as a result. The market is segmented by type and by the end user. Some key players in this market include JK Medirise, EGMED, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Egypt Coronary Stents Market Analysis

Egypt's Coronary Stents Market is expected to witness growth from $32 Mn in 2022 to $51 Mn in 2030 with a CAGR of 6.25% for the forecasted year 2022-30. Increased investment in infrastructure, energy, and industry has contributed to Egypt's recent rapid economic expansion. This expansion offers manufacturers the chance to build their companies and enter new markets. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include JK Medirise, EGMED, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Egypt Contraceptive Devices Market Analysis

Egypt's Contraceptive Devices Market is expected to witness growth from $36 Mn in 2022 to $75 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. Egypt's contemporary contraceptive prevalence rate reached 49.4% in 2020, although there is still tremendous space for market expansion. The market is segmented by type and by gender. Some key players in this market include Eva Pharma, Delta Pharma, Amoun Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Egypt Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis

This report presents a strategic analysis of the Egypt Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

subscribe to our newsletter
up